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Background. With the world becoming a global village, tuberculosis is no longer limited to endemic areas. Our case emphasizes the
impact of immigration on infectious disease epidemiology and challenges associated with diagnosis and treatment in pregnancy.
Case. A 21-year-old Hispanic female presented in preterm labor and was found to be hypoxic. Chest X-ray revealed a paratracheal
mass which a CT scan conﬁrmed. PPD test was positive. Bronchoalveolar lavage did not reveal acid-fast bacilli and biopsy revealed
caseating granulomas. Diagnosis and treatment were challenging due to constraints in radiological investigations, lack of initial
evidence of acid-fast bacilli, and toxic proﬁle of medications. Due to her high risk, she was started on antituberculosis regimen.
The diagnosis was conﬁrmed on Day 26 when Mycobacterium tuberculosis was isolated by DNA probe. Conclusion. A high index
of suspicion is required to recognize the changing face and disease spectrum of tuberculosis and initiate treatment for better out-
comes.
Copyright © 2008 M. Maddineni and M. Panda. This is an open access article distributed under the Creative Commons




the health care of population in the United States. Cases of
tuberculosis (TB) among foreign-born nationals, currently
living in the United States, account for more than half of the
total. Recognition of this fact helps in early detection. Atypi-
cal presentation may lead to misdiagnosis or a delay in diag-
nosis. Also the absence of systemic symptoms does not rule
out TB. Radiological imaging, sputum smear, and PPD only
aid in the diagnosis but a high degree of suspicion is required
to ascertain an accurate diagnosis. Establishing an early di-
agnosis of TB infection and disease in a pregnant woman is
important as it aﬀects the health of both mother and infant
[1].
2. CASE REPORT
A 21-year-old Hispanic female with a 32-week twin preg-
nancy presented in preterm labor. She had immigrated to the
United States two years prior, and her pregnancy course was
uncomplicated except for complaints of an occasional non-
productive cough. She was a nonsmoker, denied any history
of TB exposure, and was HBsAg and HIV negative. On gen-
eral exam, she was tachypneic and anxious but in no appar-
ent respiratory distress. She was found to have a low oxy-
gen saturation of 89% on room air with a respiratory rate
of 30/min and her blood pressure was 127/76mmHg. Lung
exam was clear to auscultation. Her uterine fundal height
corresponded to 32-week twin pregnancy and she had bilat-
eralpedaledema.Shewasalsonotedtohaveuterinecontrac-
tions every 1–3minutes.
She was initially admitted to the labor and delivery unit
in our hospital and subsequently transferred to the medi-
cal ICU. ABG showed pH of 7.41, PaCO2 of 29, PaO2 of 64,
bicarbonate of 18, and the base excess of −6, saturating at
93% on 21% FiO2. CBC showed WBC 9.9th/mm3,H b ,a n d
Hct 10.8g/dl and 32.8%, respectively, Platelets 432th/mm3.
The chest X-ray demonstrated a right paratracheal soft tissue
opacity measuring approximately 4 × 4cm with a slight el-
evation of the right hemidiaphragm with a linear density in
the right lower lung consistent with atelectasis (see Figure 1).
No prior X-ray was available for comparison. Patient was put
inrespiratoryisolationearlyonandthepulmonaryteamwas
consulted. CT showed a large extensive mediastinal soft tis-
sue mass in the right paratracheal region extending into the2 Infectious Diseases in Obstetrics and Gynecology
Figure 1: Chest X-ray. Right paratracheal soft tissue opacity mea-
suring approximately 4 × 4cm. Elevation of the right hemidi-
aphragmwithalineardensityintherightlowerlungconsistentwith
atelectasis.
hilar and subcarinal region. An associated atelectasis on the
right upper and lower lobe with questionable alveolar inﬁl-
trate in the right lower lobe was also found. An abdominal
ultrasoundshowedtwin-twintransfusionwithreversedend-
diastolic ﬂow on umbilical artery doppler in twin B and the
patient had an emergent low transverse cesarean section the
next day with delivery of two male infants. Infant A had Ap-
gars of 7 and 9, and infant B had Apgars of 0, 4, and 5, re-
spectively. Both infants went to the NICU, and the patient
returned to the MICU.
A PPD was placed which was positive at 10mm after 72
hours. Successful samples of sputum could not be obtained
but a bronchoscopy with endobronchial biopsy and bron-
choalveolar lavage (BAL) was done. Bronchoscopy showed a
trachea with diﬀuse mucosal swelling and the mucosal ab-




pled and the infectious disease team was consulted. There
was an abundant growth of Staphylococcus aureus but no
acid-fast bacilli (AFB), fungus, or hyphae from the BAL.
The patient was started on Vancomycin and Clindamycin
to cover Methicillin-resistant Staphylococcus aureus (MRSA)
which was later changed to Moxiﬂoxacin based on sensitivi-
ties.Transbronchialbiopsyoftherightbronchusintermedius
showed inﬂammatory and squamous debris with ulceration,
reactive squamous epithelium, and colonizing coccal bac-
teria. Endobronchial biopsy of the proximal bronchus wall
showed caseating granulomatous inﬂammation.
The treatment of this young Hispanic immigrant female
with an occasional cough, positive PPD, questionable alveo-
lar inﬁltrate, caseating granulomatous inﬂammation and no
signiﬁcant evidence of TB infection posed a deﬁnite chal-
lenge. Given her high risk for TB, she was empirically started
on INH, Rifampin, Ethambutol, and Pyrazinamide. It was
only on Day 26 that Mycobacterium tuberculosis was isolated
by DNA probe from her right lung tissue which was subse-
quently conﬁrmed on culture. The infants were started on
INH prophylaxis after placental pathology did not demon-
strate evidence of TB. Patient was discharged to home in a
stable condition to be followed up at the local TB center for
direct observation therapy.
3. DISCUSSION
Among the communicable diseases, TB is the second lead-
ing cause of death worldwide, killing nearly 2 million peo-
ple each year [2]. The World Health Organization estimates
that 2 billion people have latent TB, in addition to the 3 mil-
lion people worldwide who die each year due to TB. After
a resurgence of TB in the United States between 1985–1992,
thedeclinenoticedduring1993–2005hassloweddowncaus-
ing concerns that the progress achieved in eliminating TB is
slowing down [3]. Immigration demographics demonstrate
that Asians, blacks, and Hispanics essentially bear the bur-
d e no fT Bi ni m m i g r a n t s[ 3] .T h en u m b e ro fT Bc a s e sd u et o
foreign-born individuals has increased each year since 1993.
In 1996, 10% of the 20,973 US TB cases were among foreign-
born Hispanic persons, with the four states bordering Mex-
ico accounting for 83% of foreign-born Hispanic cases. Mex-
icans accounted for 22.9% of foreign-born patients or 8.4%
of all US cases and persons born in Central America com-
prisedanadditional4.7%offoreign-bornpatientsor1.7%of
allUScases.GuatemalaandElSalvadorcontributedtonearly
75% of these cases and the remaining were from the rest
of Central America [4]. In 2005, when compared between
foreign-born persons in the United States and US-born per-
sons, the TB rates were 8.7 times higher in immigrants; with
Hispanics, Blacks, and Asians having TB rates 7.3, 8.3, and
19.6 times higher, respectively, than those of whites [3].
M. tuberculosis is transmitted by airborne droplet nuclei,
which may contain fewer than 10 bacilli and humans are the
only known reservoir for M. tuberculosis [5]. Individuals at
high risk for M. tuberculosis infection in industrialized coun-
tries include (i) individuals likely to be exposed to or become
infected with M. tuberculosis: close contacts of a patient with
infectious TB, foreign-born individuals from high-incidence
areas, the elderly, residents of long-term care facilities (e.g.,
correctional facilities and nursing homes), IV drugs abusers,
othergroupsidentiﬁedlocallyashavingincreasedprevalence
of TB (e.g., migrant farm workers or homeless persons), and
individuals who may have occupational exposure to TB; and
(ii) individuals at high risk of developing TB disease once
infected: individuals recently infected with M. tuberculosis
(within the past 2 years), HIV-infected individuals, individ-
uals with immunosuppressing conditions or medication use,
individuals with a history of inadequately treated TB, and in-
fants. Chances that an individual acquires infection depend
on the infectiousness of the index case, duration of the ex-
posure, environment (crowding, poor ventilation), and viru-
lence of the organism.
Atypical presentations and slow conﬁrmation by culture
often delay the diagnosis and treatment of patients with TB.
Other reasons include an under use of tuberculin skin tests,
misinterpretation of unusual chest X-rays, and waiting for
culture results in patients with AFB-negative smears [6].
Chest radiography is often reliable and an important in-
vestigation.Generally,inTB,asegmentalpneumonicprocess
is seen but may be too small to visualize radiographically orM. Maddineni and M. Panda 3
Figure 2: Computer tomography of the chest. Extensive mediasti-
nal soft tissue mass in the right paratracheal region extending into
the hilar and subcarinal region.
complicated by atelectasis from the raised diaphragm com-
pressingthelowerlungﬁeldsinpregnancy[7,8].Upperzone
shadowing, often bilateral and likely associated with cavita-
tion or miliary shadowing are the classic ﬁndings. New ﬁnd-
ings like soft shadowing amongst old, ﬁbrotic changes gen-
erally indicate a relapse. Paratracheal, mediastinal, and hilar
lymphadenopathy,thoughnotunusualinAfricanandIndian
patients with TB or in children, are generally unusual in im-
munocompetent adults like ours. In patients infected with
HIV, the radiological appearances could often be nonspeciﬁc
[9].
In our patient, the situation was complicated by a right
lower lobe inﬁltrate. The inﬁltrate could have been misdiag-
nosed as atelectasis in a woman with a 32-week twin preg-
nancy. Tuberculin skin test in our patient was read as 10mm.
Five millimeters is considered to be positive in individuals
with HIV, on steroid therapy, or in individuals in close con-
tact with a person with active TB. Our patient denied any
contact with TB. Larger reactions of greater than or equal to
10mm are considered positive in recent (within the last ﬁve
years) immigrants from high-prevalence countries, in indi-
viduals with diabetes, renal failure, and health-care workers,
amongothers.Ourpatientfallsintothiscategory.Inindivid-
uals with no known risks for TB, a positive reaction requires
a 15mm or greater induration [10].
Many patients with suspected pulmonary TB do not pro-
duce sputum spontaneously or are smear-negative for AFB.
We could not obtain sputum sample in our patient due to
absence of a productive cough and sputum induction was
also unsuccessful. Though the BAL sample did not show any
AFB, the biopsy showed caseating granuloma which could
be found both in tubercular and nontubercular mycobacte-
rialinfectionsorfungalinfectionsduetoCoccidioidesimmitis
and Histoplasma capsulatum.I tw a su l t i m a t e l yaD N Ap r o b e
from her lung tissue that grew M. tuberculosis after 26 days.
Table 1: Accuracy of various methods of diagnosis of tuberculosis
with their sensitivities and speciﬁcities [12–14].
Testing methods Sensitivity Speciﬁcity
(1) Chest X-ray 66–77 66–76
(2) TST 75–90 75–90
(3) RD1-based Gammainterferon tests 80–95 95–100
(4) Acid fast smear 60 92
(5) Culture 90 99.6
(6) PCR (smear-positive sample) 96 85
(7) (Smear-negative sample) 66 98
With the use of PCR, nucleic acid sequences unique to
M. tuberculosis can be detected directly in clinical specimens
with better accuracy and urgency than AFB smear and cul-
ture,respectively.Probesareusedforrapididentiﬁcationand
maximizing cost eﬀectiveness. Used alone or in combina-
tionwithotheridentiﬁcationmethods,theyserveasasubsti-
tute for biochemical testing and are also more accurate [11].
Molecular tests in combination with “classic tests” can en-
hancethediagnosticabilityparticularlyinpauci-bacillaryin-
fections and in patients with atypical presentations like ours.
The risk of TB to health-care workers is real. In the early
1990s, many urban US hospitals reported puriﬁed protein
derivative (PPD) conversion rates in health-care workers of
3–5% [15]. A survey of US hospitals conducted by the Cen-
tersforDiseaseControlandPrevention(CDC)foundamean
conversion rate of 1.6% [16, 17]. More recent studies have
demonstrated rates of around 1% annually. Eﬃcient con-
trol of nosocomial TB is compromised by the same diﬃcul-
ties complicating community control hence a high degree of
suspicion is required to recognise and isolate patients with
TB. An improved clinical acumen, development of rapid di-
agnostic tests, and the institution of early empiric therapy
are desirable to control this disease. We combined the use of
bronchoscopy and M. tuberculosis complex-PCR which pro-
vided a good diagnostic yield in our patient.
An early diagnosis of TB infection in a pregnant woman
is important as better results are seen in women who are
detected with TB and have been treated before the onset of
pregnancy or earlier in its course, when compared with un-
treated patients with TB [18]. Infant and maternal mortal-
ity are between 30% and 40% in untreated active TB cases
[19]. Treatment should also be initiated when the proba-
bility is moderate-to-high. Although the drugs in the ini-
tial treatment regime cross the placenta, these concentra-
tions do not appear to have harmful eﬀect on the fetus [20].
Pregnant women with TB should also be tested for HIV
as there is a higher incidence of extrapulmonary TB and
multidrug-resistantTB(MDRTB)inthissetofpatients[18].
Breast feeding should not be discouraged in women being
treatedwithﬁrst-lineantituberculosisdrugsbecausethecon-
centrations in the breast milk are subtherapeutic and too
low to produce toxicity in the nursing new born. The risks
of second-line medications are unknown. The eﬀect would
likely be much lower if the mother breast feeds before taking4 Infectious Diseases in Obstetrics and Gynecology
the medication. Similarly, breast milk is also inadequate as a
treatment option for TB or latent TB infection in newborns
[19]. Close follow up of patients is essential since current
therapy for TB infection is long and suboptimal adherence
may result in failure of therapy.
Congenital TB is rare with symptoms typically develop-
ing during the second or third week of life which include
poor feeding, poor weight gain, cough, lethargy, and irri-
tability. Other symptoms include fever, ear discharge, and
skin lesions. Two possible routes of M. tuberculosis infection
in utero are (a) hematogenous infection through the um-
bilical vein, with primary lesions in the liver and occasional
porta hepatis lymphadenopathy; and (b) prenatal aspiration
ofinfectedﬂuid,withpredominantpulmonaryandgastroin-
testinal disease [21, 22]. The criteria for congenital TB re-
quires the infant to have a tuberculous lesion (e.g., inﬁltrates
on the chest radiograph or granulomas) and at least one of
the following: (a) onset during the ﬁrst week of life, (b) pres-
ence of a primary hepatic TB complex or caseating hepatic
granulomas, (c) infection of the placenta or maternal genital
tract, or (d) exclusion of postnatal transmission [22].
T h er o l eo fB a c i l l u so fC a l m e t t e - G u ´ erin (BCG) vaccine
in preventing TB in adults is debatable due to its variable
eﬃcacy (0–80%) [23]. Its eﬃcacy in prevention of tuber-
culous meningitis and miliary TB in young children has
been easier to document than in adults or in the preven-
tion of pulmonary TB in both children and adults [24]. The
Centers for Disease Control has made the following recom-
mendations concerning BCG vaccination in the US [25]. (i)
BCG vaccination should be considered in infants and chil-
dren 5 years if the child is exposed continually to an un-
treated or ineﬀectively treated patient with infectious pul-
monary TB, if the child cannot be separated from the pres-
ence of the infectious patient or be given long-term pri-
mary preventive therapy, or if the child is exposed contin-
ually to a patient with infectious pulmonary TB caused by
M.tuberculosisstrainsresistanttoisoniazidandrifampinand
the child cannot be separated from the presence of the in-
fectious patient. (ii) Health-care workers in high-risk set-
tings should be considered on an individual basis in set-
tings in which a high percentage of TB patients are in-
fected with M. tuberculosis strains resistant to both isoni-
azid and rifampin, transmission and subsequent infection
are likely and where comprehensive TB infection-control
precautions have been implemented and have not been suc-
cessful.
4. CONCLUSION
Our case emphasizes the signiﬁcance of identifying infec-
tiousdiseaseslikeTBindevelopingcountriesduetoachange
in demographics. It also underscores the importance of an
early diagnosis and treatment even in the backdrop of con-
founding evidence in pregnant women due to better mater-
nal and perinatal outcomes. A heightened index of suspicion
and awareness of the rapid advances and innovations made
in the diagnosis of TB is also essential for better control of
this disease.
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